Connect your AI

Nurix Therapeutics, Inc. NRIX Price / book

Price / book at other companies

Kymera TherapeuticsKYMR

4.4×+2.2×

Monte Rosa Therapeutics, Inc.GLUE

2.5×+1.5×

Stoke Therapeutics, Inc.STOK

4.9×+3.8×

Viridian Therapeutics, Inc.VRDN

3.1×+1.3×

Nuvation BioNUVB

4.7×+3.2×

Ultragenyx PharmaceuticalRARE

316.5×+303×

Other financials

Income statement

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Calculated from Nurix Therapeutics, Inc.’s reported figures.

market cap/total stockholders equity=3.4×

Based on the most recent quarter.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Nurix Therapeutics, Inc.'s price / book?: Nurix Therapeutics, Inc. (NRIX) reported price / book of 3.4× in Q4 2025.
How has Nurix Therapeutics, Inc.'s price / book changed year-over-year?: Nurix Therapeutics, Inc.'s price / book increased by 40.1% year-over-year, from 2.4× to 3.4×.
What is the long-term trend for Nurix Therapeutics, Inc.'s price / book?: Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s price / book has grown at a -10.2% compound annual growth rate (CAGR), from 5.7× to 3.3×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.